Table 2 Symptoms and HQOL preoperatively and 6Â months postoperatively
| Â | Group 1 | Group 1 | Â | Group 2 | Group 2 | Â | Group 3 | Group 3 | Â |
|---|---|---|---|---|---|---|---|---|---|
Pre | Post | Â | Pre | Post | Â | Pre | Post | Â | |
N = 57 | N = 57 | p | N = 56 | N = 56 | p | N = 58 | N = 58 | p | |
Symptoms - VAS | |||||||||
 Nasal obstruction | 70.4(21.9) | 29.1 (26.6) | 0.01 | 71.8 (16.4) | 27.5 (22.5) | 0.01 | 66.8 (23.6) | 37.2 (24.8) | 0.01 |
 Nasal discharge | 40.6 (31.9) | 20.5 (25.4) | 0.01 | 39.8 (32.1) | 24.2 (28.0) | 0.01 | 42.0 (33.6) | 29.5 (30.0) | 0.02 |
 Sneezing | 32.2 (28.7) | 18.6 (23.4) | 0.01 | 27.8 (25.3) | 13.2 (19.6) | 0.01 | 26.4 (2540) | 20.9 (20.9) | 0.18 |
 Snoring | 50.3 (36.2) | 22.2 (27.6) | 0.01 | 53.2 (32.0) | 27.4 (26.8) | 0.01 | 45.8 (36.3) | 32.7 (30.0) | 0.01 |
 Oral breathing | 67.2 (28.5) | 26.3 (29.7) | 0.01 | 58.7 (30.8) | 22.7 (25.9) | 0.01 | 51.9 (31.9) | 31.9 (30.5) | 0.01 |
 Reduced general health | 47.7 (33.8) | 14.1 (22.0) | 0.01 | 43.4 (28.9) | 13.0 (20.5) | 0.01 | 40.4 (31.5) | 18.4 (23.2) | 0.01 |
HQOLÂ - SNOT - 20 | |||||||||
 Total SNOT 20 | 1.58 (0.78) | 0.97 (0.80) | 0.01 | 1.70 (0.84) | 0.93 (0.71) | 0.01 | 1.59 (0.83) | 1.15 (0.87) | 0.01 |
Subset: | |||||||||
 Rhinologic | 1.83 (0.97) | 1.18 (0.82) | 0.01 | 1.82 (1.05) | 1.17 (0.85) | 0.01 | 1.84 (0.94) | 1.44 (1.06) | 0.01 |
 Ear/facial | 0.75 (0.75) | 0.47 (0.67) | 0.01 | 1.05 (0.91) | 0.50 (0.58) | 0.01 | 1.10 (0.86) | 0.79 (0.92) | 0.01 |
 Sleep | 2.25 (1.33) | 1.33 (1.28) | 0.01 | 2.23 (1.31) | 1.15 (1.20) | 0.01 | 2.01 (1.46) | 1.43 (1.38) | 0.01 |
 Psychological | 1.45 (1.16) | 0.82 (1.10) | 0.01 | 1.68 (1.07) | 0.81 (0.93) | 0.01 | 1.39 (1.04) | 0.90 (1.03) | 0.01 |
HQOL - SF- 36 | |||||||||
 PF physical functioning | 89.5 (9.89) | 91.6 (12.3) | 0.02 | 83.6 (15.2) | 88.1 (19.3) | 0.01 | 84.5 (16.9) | 87.7 (18.9) | 0.14 |
 RP role-physical | 68.3 (22.2) | 75.2 (20.5) | 0.01 | 61.6 (28.8) | 71.2 (24.4) | 0.01 | 69.3 (22.3) | 72.2 (25.0) | 0.26 |
 BP bodily pain | 71.5 (26.0) | 76.9 (26.1) | 0.03 | 66.0 (30.2) | 71.8 (29.0) | 0.13 | 68.5 (26.7) | 72.7 (26.3) | 0.35 |
 GH general health | 69.7 (21.3) | 73.6 (23.8) | 0.07 | 62.4 (22.5) | 67.4 (23.8) | 0.02 | 59.5 (23.1) | 64.6 (23.5) | 0.03 |
 VT vitality | 48.7 (19.4) | 53.8 (18.5) | 0.02 | 44.4 (15.6) | 52.1 (16.0) | 0.01 | 46.1 (18.4) | 54.3 (19.8) | 0.01 |
 SF social functioning | 80.5 (23.3) | 86.2 (20.8) | 0.01 | 76.8 (23.9) | 80.4 (23.9) | 0.20 | 80.2 (23.0) | 85.6 (21.4) | 0.09 |
 RE role-emotional | 85.7 (20.8) | 90.8 (16.9) | 0.08 | 81.8 (25.1) | 84.3 (24.0) | 0.16 | 91.4 (15.5) | 91.4 (18.3) | 0.55 |
 MH general mental health | 69.2 (12.9) | 70.9 (14.4) | 0.20 | 66.6 (11.3) | 69.1 (12.0) | 0.04 | 70.6 (10.3) | 72.1 (11.0) | 0.18 |
 Physical health summary | 74.9 (15.2) | 79.3 (17.3) | 0.01 | 68.5 (20.4) | 74.6 (20.9) | 0.01 | 70.5 (17.0) | 74.3 (19.8) | 0.05 |
 Mental health summary | 71.5 (16.7) | 76.4 (17.3) | 0.01 | 66.7 (17.2) | 71.0 (18.4) | 0.01 | 69.3 (15.1) | 74.0 (17.1) | 0.01 |